Cite
HARVARD Citation
Tessen, H. et al. (n.d.). 3106 Open label, multicenter, prospective non-interventional study to monitor the safety and effectiveness of Bevacizumab with chemotherapy in patients with NSCLC under conditions of routine clinical practice in Germany. European journal of cancer. pp. S637-. [Online].